NeoGenomics NEO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$108.03M-37.2% | -$78.73M+10.5% | -$87.97M+39.0% | -$144.25M-1,628% | ||
| $36.07M-7.7% | $39.1M+4.4% | $37.45M+5.9% | $35.37M+17.2% | ||
| $41.32M+65.6% | $24.94M+42.9% | $17.45M-29.3% | $24.67M+9.9% | ||
| $5.23M— | —— | —— | -$65.99M-147% | ||
| $27.01M-34.2% | $41.06M+42.8% | $28.75M-6.9% | $30.89M-51.8% | ||
| -$12.34M— | —— | $76.71M— | —— | ||
| —— | $4.65M+2.0% | $4.55M-61.5% | $11.83M-98.4% | ||
| -$216.79M-984% | $24.52M-69.1% | $79.31M+248% | -$53.65M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.4M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $27.5M of capital expenditures, NeoGenomics's free cash flow was -$51.3M over the trailing twelve months, down 19.8% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
